Authors’ Reply to Ravi Jandhyala’s Comment on “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments”
- 53 Downloads
Compliance with Ethical Standards
This work was not funded.
Conflict of interest
Patricia McGettigan, Carla Alonso Olmo, Kelly Plueschke, Mireia Castillon, Daniel Zondag, Priya Bahri, Xavier Kurz and Peter Mol have no conflicts of interest that are directly relevant to the content of this letter.
- 1.McGettigan P, Alonso CO, Plueschke K, Castillon M, Nogueras DZ, Bahri P, et al. Patient registries: an underused resource for medicines evaluation: operational proposals for increasing the use of patient registries in regulatory assessments. Drug Saf. 2019. https://doi.org/10.1007/s40264-019-00848-9.CrossRefPubMedGoogle Scholar
- 7.European Medicines Agency. Patient registries. https://www.ema.europa.eu/en/human-regulatory/post-authorisation/patient-registries. Accessed 18 Sep 2019.